The number of allogeneic bone marrow and stem cell transplants is increasing worldwide. Graft-versus-host disease (GvHD) is a serious complication of this type of transplant. The incidence of acute GvHD varies widely, ranging from 10-80% depending on risk factors.1GvHD is a prominent cause of death in bone marrow and stem cell recipients and has important implications on immunosuppressive medications.2
This is a companion discussion topic for the original article at https://patient.info/doctor/multisystem-diseases/graft-vs-host-disease